July 27, 2009 - Teva Pharmaceutical Industries Ltd. announced on Friday that it had settled its patent infringement lawsuit with Johnson & Johnson. Teva, the world's largest manufacturer of generic drugs, will pay J&J a royalty based on the sales of the generic Ortho Tri-Cyclen that it shipped.
Teva also obtained a license to put its generic version of the contraceptive back on the market on December 31, 2015.
J&J's patent on the drug expires in 2019, according to a J&J spokesman.